“Khavinson bioregulators” is the umbrella term for a family of short synthetic peptides — mostly di-, tri-, and tetrapeptides — that came out of research led by Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology. The historical work began with complex peptide fractions isolated from animal tissues, but the compounds studied and catalogued today are defined, chemically synthesized short peptides with known amino-acid sequences. This guide explains the peptide-bioregulator concept, the tissue-specificity hypothesis that organizes the family, and the individual compounds grouped by the organ system each was associated with in the research literature.
What the Khavinson bioregulator concept actually is
The core idea proposed by the Khavinson group is that very short peptides can act as signaling molecules that regulate gene activity. In their model, a peptide only a few amino acids long is small enough to enter the cell and reach the nucleus, where it has been proposed to interact with DNA and modulate the expression of specific genes. A systematic review from the group catalogued peptide effects on gene expression across the endocrine, nervous, and immune systems and argued that a single short peptide can influence the activity of multiple genes (Khavinson et al., Molecules, 2021). A companion mechanistic paper used molecular docking to model how 19 short peptides might bind particular DNA sequences, framing the proposed mode of action as direct peptide–DNA interaction (Khavinson et al., Bull Exp Biol Med, 2016).
The second organizing claim is tissue specificity. The hypothesis holds that each peptide is preferentially associated with one tissue or organ — a pineal peptide, a prostate peptide, a liver peptide, and so on — and that this association traces back to the tissue the original peptide fraction was derived from. Work from the group described short peptides such as the AEDG and AEDP sequences directing differentiation pathways in skin, connective, and neural cell systems in culture (Khavinson et al., Stem Cell Rev Rep, 2020). It is worth being precise about what that body of research is: these are largely experimental and clinical studies measured in cell cultures, rodent models, and human cohorts conducted predominantly by a single research group, summarized in review form (Khavinson, Neuro Endocrinol Lett, 2002; Anisimov et al., Biogerontology, 2010). The sections below describe each compound by name, sequence class, and its reported tissue association — not by any claimed result.
Pineal and central nervous system peptides
This is the most heavily studied corner of the family, anchored by the pineal peptides that launched the original aging research.
- Pinealon — a tripeptide (Glu-Asp-Arg) associated with the brain and central nervous system in Khavinson-group research.
- Epitalon — a tetrapeptide (Ala-Glu-Asp-Gly) derived from work on pineal-gland peptide fractions; it is the synthetic counterpart of the pineal peptide preparation that featured in the group’s foundational aging studies.
- N-Acetyl Epitalon — an N-terminally acetylated form of the same Ala-Glu-Asp-Gly tetrapeptide, a modification intended to alter the molecule’s stability profile.
Urogenital and reproductive peptides
Several bioregulators were associated with the prostate, gonads, and related tissues.
- Prostamax — a tetrapeptide (Lys-Glu-Asp-Pro) associated with prostate tissue.
- Testagen — a short synthetic peptide associated with the reproductive system in Khavinson-group research.
Vascular and cardiac peptides
This group covers the bioregulators associated with blood vessels and the heart.
- Vesugen — a tripeptide (Lys-Glu-Asp) associated with the vascular wall and blood vessels.
- Cardiogen — a tetrapeptide (Ala-Glu-Asp-Arg) associated with cardiac (heart-muscle) tissue.
Liver, pancreas, and digestive peptides
The metabolic and digestive organs each have an associated peptide in the catalogue.
- Livagen — a tetrapeptide (Lys-Glu-Asp-Ala) associated with the liver.
- Ovagen — a tripeptide (Glu-Asp-Leu) associated with the liver and digestive tissues.
- Pancragen — a tetrapeptide (Lys-Glu-Asp-Trp) associated with the pancreas.
Respiratory and connective-tissue peptides
This group covers the lung and airway peptides alongside the cartilage-associated compound. Note that Chonluten is a respiratory (lung) peptide — a point worth flagging because it is sometimes mislabeled elsewhere.
- Chonluten — a tripeptide (Glu-Asp-Gly) associated with the respiratory system, specifically lung tissue.
- Bronchogen — a tetrapeptide (Ala-Glu-Asp-Leu) associated with the bronchi and respiratory tract.
- Cartalax — a tripeptide (Ala-Glu-Asp) associated with cartilage and connective tissue.
Immune and thymic peptides
The thymus and broader immune system account for the oldest peptides in the lineage; the thymic preparations were among the earliest studied by the group (Khavinson, Neuro Endocrinol Lett, 2002).
- Vilon — a dipeptide (Lys-Glu) associated with the thymus and immune system.
- Thymogen — a dipeptide (Glu-Trp) associated with the thymus and immune function.
- Crystagen — a short synthetic peptide associated with the immune system.
- Cortagen — a tetrapeptide (Ala-Glu-Asp-Pro) associated with nervous-system and cortical tissue in Khavinson-group research.
How to read the chemistry across the family
A useful pattern emerges when these sequences are lined up: the glutamic-acid–aspartic-acid (Glu-Asp) core recurs across most of the family, with the differences between compounds coming down to one or two flanking residues. Cartalax (Ala-Glu-Asp), Chonluten (Glu-Asp-Gly), and Ovagen (Glu-Asp-Leu) differ by a single terminal amino acid, yet were each assigned to a different tissue in the research. The tissue-specificity hypothesis rests on the proposal that those small sequence differences are what determine which genes a given peptide is reported to engage (Khavinson et al., Molecules, 2021). Whether that level of specificity holds up is an open scientific question — much of the supporting literature originates from a single research lineage — but it is the organizing principle behind how the catalogue is named and grouped.
Frequently asked questions
Are Khavinson bioregulators tissue extracts or synthetic peptides?
The compounds catalogued and studied today are synthetic short peptides with defined amino-acid sequences. The historical research that established the concept began with peptide fractions isolated from animal tissues, but the modern bioregulators are chemically synthesized di-, tri-, and tetrapeptides, not tissue extracts.
What does “bioregulator” mean in this context?
It refers to the hypothesis from the Khavinson group that a short peptide can act as a regulatory signal — specifically, that it can reach the cell nucleus and influence the expression of particular genes. The systematic review by Khavinson and colleagues (Molecules, 2021) catalogues the proposed gene-regulatory effects that the term is built on.
What is Pinealon and what tissue is it associated with?
Pinealon is a tripeptide (Glu-Asp-Arg) that was associated with the brain and central nervous system in Khavinson-group research, placing it in the same pineal/CNS cluster as Epitalon.
What is Prostamax associated with?
Prostamax is a tetrapeptide (Lys-Glu-Asp-Pro) associated with prostate tissue in the research literature on tissue-specific peptide bioregulators.
Why are so many bioregulators chemically similar?
Most share a glutamic-acid–aspartic-acid (Glu-Asp) core, differing only in one or two flanking residues. The tissue-specificity hypothesis proposes that these small sequence differences account for the distinct organ associations reported across the family (Khavinson et al., Bull Exp Biol Med, 2016).
How strong is the evidence behind these compounds?
Much of the published research comes from a single research lineage and is summarized largely in review form (for example Khavinson, Neuro Endocrinol Lett, 2002; Anisimov et al., Biogerontology, 2010). The studies report measurements in cell cultures, rodent models, and human cohorts; readers evaluating the literature should weigh the concentration of the source material within one group.
References
- Khavinson VK, et al. Peptide Regulation of Gene Expression: A Systematic Review. Molecules. 2021. PMID: 34834147.
- Khavinson VKh, et al. Short Peptides Regulate Gene Expression. Bulletin of Experimental Biology and Medicine. 2016. PMID: 27909961.
- Khavinson V, et al. Peptide Regulation of Cell Differentiation. Stem Cell Reviews and Reports. 2020. PMID: 31808038.
- Khavinson VKh. Peptides and Ageing. Neuro Endocrinology Letters. 2002. PMID: 12374906.
- Anisimov VN, et al. Peptide bioregulation of aging: results and prospects. Biogerontology. 2010. PMID: 19830585.
For research use only. The products and materials discussed are intended for laboratory research purposes and are not for human or veterinary use, diagnosis, or treatment. This article describes the chemical structure and published pharmacological research of a compound and does not constitute a claim of any effect in any individual.
